BioNexus Gene Lab Additional Paid-in Capital 2019-2024 | BGLC
BioNexus Gene Lab additional paid-in capital from 2019 to 2024. Additional paid-in capital can be defined as the excess over par value paid for common securities.
| BioNexus Gene Lab Annual Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2024 | $-5 |
| 2023 | $-5 |
| 2022 | $-5 |
| 2021 | $-5 |
| 2020 | $-5 |
| 2019 | $-5 |
| 2018 | $-5 |
| BioNexus Gene Lab Quarterly Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-5 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-5 |
| 2024-03-31 | $-5 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $-5 |
| 2023-03-31 | $-5 |
| 2022-12-31 | $-5 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-5 |
| 2021-12-31 | $-5 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-5 |
| 2021-03-31 | $-5 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-5 |
| 2020-03-31 | $-5 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-5 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| Elevance Health (ELV) | United States | $94.145B | 12.15 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| ICON (ICLR) | Ireland | $11.324B | 10.53 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |